TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in TScan Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 89
- +9 vs. Q2 2024
- Shares held
- 41.8M
- +4.82M (+13.0%) vs. Q2 2024
- Total value
- $208.3M
- −$8.14M (−3.8%) vs. Q2 2024
- New holders
- 20
- 25 more added
- Sold out
- 11
- 18 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lazard Asset Management LLC | 70 | $0 | 0.00% | −106−60.2% | Reduced |
| CWM, LLC | 7 | $0 | 0.00% | +7 | New |
| Capital Advisors, Ltd. LLC | 2 | $0 | 0.00% | +2 | New |
| Atlas Capital Advisors LLC | 18 | $89 | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 68 | $339 | 0.00% | +68 | New |
| Nisa Investment Advisors, LLC | 121 | $603 | 0.00% | +121 | New |
| GAMMA Investing LLC | 142 | $707 | 0.00% | +142 | New |
| FMR LLC | 425 | $2.12K | 0.00% | +425 | New |
| Macquarie Group Ltd | 1,047 | $5.21K | 0.00% | +1,047 | New |
| Amalgamated Bank | 1,329 | $7.00K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 2,782 | $13.9K | 0.00% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 3,200 | $15.9K | 0.00% | +3,200 | New |
| Ameritas Investment Partners, Inc. | 3,762 | $18.7K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 3,937 | $19.6K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 4,477 | $22.3K | 0.00% | +4,477 | New |
| New York State Common Retirement Fund | 6,169 | $30.7K | 0.00% | −13,924−69.3% | Reduced |
| Tower Research Capital LLC (TRC) | 8,049 | $40.1K | 0.00% | +3,825+90.6% | Added |
| Waldron Private Wealth LLC | 10,000 | $49.8K | 0.00% | 00.0% | Unchanged |
| Aries Wealth Management | 10,000 | $49.8K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,176 | $50.7K | 0.00% | +10,176 | New |
| Cornercap Investment Counsel Inc | 10,788 | $53.7K | 0.02% | −12,152−53.0% | Reduced |
| Advisor Group Holdings, Inc. | 12,245 | $61.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 12,343 | $62.0K | 0.00% | +8,732+241.8% | Added |
| Price T Rowe Associates Inc | 12,301 | $62.0K | 0.00% | 00.0% | Unchanged |
| AQR Capital Management LLC | 12,913 | $64.3K | 0.00% | +12,913 | New |
| Wells Fargo & Company | 13,846 | $69.0K | 0.00% | −40−0.3% | Reduced |
| Voya Investment Management LLC | 13,911 | $69.3K | 0.00% | +308+2.3% | Added |
| Manufacturers Life Insurance Company, The | 14,798 | $73.7K | 0.00% | −585−3.8% | Reduced |
| SG Americas Securities, LLC | 15,563 | $78.0K | 0.00% | +15,563 | New |
| Two Sigma Investments, LP | 15,745 | $78.4K | 0.00% | +15,745 | New |
| Invesco Ltd. | 18,016 | $89.7K | 0.00% | −481,858−96.4% | Reduced |
| UBS Group AG | 19,344 | $96.3K | 0.00% | +6,699+53.0% | Added |
| Corebridge Financial, Inc. | 20,531 | $102.2K | 0.00% | −127−0.6% | Reduced |
| EntryPoint Capital, LLC | 20,620 | $102.7K | 0.06% | −1,279−5.8% | Reduced |
| Deutsche Bank AG | 20,638 | $102.8K | 0.00% | 00.0% | Unchanged |
| Letko, Brosseau & Associates Inc | 20,700 | $103.1K | 0.00% | 00.0% | Unchanged |
| Mirae Asset Global ETFs Holdings Ltd. | 21,267 | $105.9K | 0.00% | +21,267 | New |
| XTX Topco Ltd | 22,438 | $111.7K | 0.01% | +22,438 | New |
| MetLife Investment Management | 23,363 | $116.3K | 0.00% | +13,164+129.1% | Added |
| Citigroup Inc | 27,793 | $138.4K | 0.00% | +19,347+229.1% | Added |
| JPMorgan Chase & Co | 31,805 | $158.4K | 0.00% | +15,441+94.4% | Added |
| Cubist Systematic Strategies, LLC | 32,137 | $160.0K | 0.00% | +32,137 | New |
| DC Investments Management, LLC | 35,563 | $177.1K | 0.12% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 38,300 | $190.7K | 0.00% | 00.0% | Unchanged |
| Pale Fire Capital SE | 43,723 | $217.7K | 0.03% | +22,150+102.7% | Added |
| Rhumbline Advisers | 47,203 | $235.1K | 0.00% | +336+0.7% | Added |
| Millennium Management LLC | 48,672 | $242.4K | 0.00% | +20,783+74.5% | Added |
| Troluce Capital Advisors LLC | 52,914 | $263.5K | 0.05% | −39,918−43.0% | Reduced |
| Qube Research & Technologies Ltd | 54,564 | $271.7K | 0.00% | −23,821−30.4% | Reduced |
| ExodusPoint Capital Management, LP | 55,845 | $278.0K | 0.00% | +55,845 | New |
| Barclays PLC | 58,067 | $289.2K | 0.00% | +44,903+341.1% | Added |
| Nuveen Asset Management, LLC | 69,962 | $348.4K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 71,800 | $357.6K | 0.01% | −593,729−89.2% | Reduced |
| Renaissance Technologies LLC | 74,000 | $368.5K | 0.00% | −6,000−7.5% | Reduced |
| Walleye Capital LLC | 84,699 | $421.8K | 0.00% | −22,966−21.3% | Reduced |
| Bank of New York Mellon Corp | 88,314 | $439.8K | 0.00% | −28,344−24.3% | Reduced |
| NewEdge Wealth, LLC | 91,463 | $455.5K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 93,876 | $467.5K | 0.00% | −5,160−5.2% | Reduced |
| Bank of America Corp | 97,211 | $484.1K | 0.00% | +53,429+122.0% | Added |
| Stifel Financial Corp | 99,133 | $493.7K | 0.00% | +3,733+3.9% | Added |
| Jacobs Levy Equity Management, Inc | 103,440 | $515.1K | 0.00% | +103,440 | New |
| Woodline Partners LP | 108,584 | $540.7K | 0.00% | −54,908−33.6% | Reduced |
| Charles Schwab Investment Management Inc | 112,941 | $562.4K | 0.00% | 00.0% | Unchanged |
| Wellington Management Group LLP | 126,345 | $629.2K | 0.00% | +35,404+38.9% | Added |
| Dimensional Fund Advisors LP | 134,297 | $668.9K | 0.00% | +122,415+1,030.3% | Added |
| Brown Brothers Harriman & Co | 143,051 | $712.4K | 0.00% | +67,027+88.2% | Added |
| Goldman Sachs Group Inc | 158,624 | $789.9K | 0.00% | +123,356+349.8% | Added |
| Marshall Wace, LLP | 165,160 | $822.5K | 0.00% | −142,327−46.3% | Reduced |
| Tocqueville Asset Management L.P. | 205,730 | $1.02M | 0.02% | −4,100−2.0% | Reduced |
| Morgan Stanley | 299,319 | $1.49M | 0.00% | +57,647+23.9% | Added |
| Northern Trust Corp | 324,276 | $1.61M | 0.00% | +226,764+232.5% | Added |
| Standard Life Aberdeen plc | 371,655 | $1.85M | 0.00% | +79,511+27.2% | Added |
| DC Funds, LP | 630,000 | $3.14M | 60.91% | 00.0% | Unchanged |
| State Street Corp | 756,499 | $3.77M | 0.00% | +148,414+24.4% | Added |
| Checkpoint Capital L.P. | 825,341 | $4.11M | 2.04% | +825,341 | New |
| StemPoint Capital LP | 860,951 | $4.29M | 1.29% | +15,882+1.9% | Added |
| Geode Capital Management, LLC | 973,466 | $4.85M | 0.00% | +72,967+8.1% | Added |
| Great Point Partners LLC | 1,016,375 | $5.06M | 1.53% | +75,544+8.0% | Added |
| Simplify Asset Management Inc. | 1,046,916 | $5.21M | 0.36% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $5.36M | 0.29% | 00.0% | Unchanged |
| Deer Management Co. LLC | 1,245,504 | $6.20M | 0.98% | 00.0% | Unchanged |
| Propel Bio Management, LLC | 2,087,139 | $10.4M | 6.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,346,894 | $11.7M | 0.00% | +213,281+10.0% | Added |
| Baker Bros. Advisors LP | 2,784,792 | $13.9M | 0.14% | 00.0% | Unchanged |
| BVF Inc | 2,989,474 | $14.9M | 0.44% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 4,400,000 | $21.9M | 0.04% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,632,876 | $23.1M | 0.00% | +4,632,876 | New |
| EcoR1 Capital, LLC | 5,000,000 | $24.9M | 0.85% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 5,224,600 | $26.0M | 9.22% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −353,886−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −157,963−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −137,490−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −120,454−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −60,400−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −47,481−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,290−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −18,651−100.0% | Sold out |
| Marathon Trading Investment Management LLC | 0 | $0 | 0.00% | −13,600−100.0% | Sold out |
| Privium Fund Management (UK) Ltd | 0 | $0 | 0.00% | −12,103−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,792−100.0% | Sold out |